Connection

HUI-LIN PAN to Rats, Sprague-Dawley

This is a "connection" page, showing publications HUI-LIN PAN has written about Rats, Sprague-Dawley.
Connection Strength

8.520
  1. Calcineurin regulates synaptic Ca2+-permeable AMPA receptors in hypothalamic presympathetic neurons via a2d-1-mediated GluA1/GluA2 assembly. J Physiol. 2024 May; 602(10):2179-2197.
    View in: PubMed
    Score: 0.654
  2. mGluR5 from Primary Sensory Neurons Promotes Opioid-Induced Hyperalgesia and Tolerance by Interacting with and Potentiating Synaptic NMDA Receptors. J Neurosci. 2023 08 02; 43(31):5593-5607.
    View in: PubMed
    Score: 0.155
  3. NMDA Receptors at Primary Afferent-Excitatory Neuron Synapses Differentially Sustain Chemotherapy- and Nerve Trauma-Induced Chronic Pain. J Neurosci. 2023 05 24; 43(21):3933-3948.
    View in: PubMed
    Score: 0.153
  4. Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via a1- and a2-Adrenergic Receptors. ACS Chem Neurosci. 2023 04 05; 14(7):1261-1277.
    View in: PubMed
    Score: 0.152
  5. Brief Opioid Exposure Paradoxically Augments Primary Afferent Input to Spinal Excitatory Neurons via a2d-1-Dependent Presynaptic NMDA Receptors. J Neurosci. 2022 12 14; 42(50):9315-9329.
    View in: PubMed
    Score: 0.148
  6. Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain. J Biol Chem. 2022 06; 298(6):101999.
    View in: PubMed
    Score: 0.143
  7. Calcineurin Regulates Synaptic Plasticity and Nociceptive Transmission at the Spinal Cord Level. Neuroscientist. 2022 12; 28(6):628-638.
    View in: PubMed
    Score: 0.138
  8. a2d-1 switches the phenotype of synaptic AMPA receptors by physically disrupting heteromeric subunit assembly. Cell Rep. 2021 07 20; 36(3):109396.
    View in: PubMed
    Score: 0.135
  9. a2d-1 Upregulation in Primary Sensory Neurons Promotes NMDA Receptor-Mediated Glutamatergic Input in Resiniferatoxin-Induced Neuropathy. J Neurosci. 2021 07 07; 41(27):5963-5978.
    View in: PubMed
    Score: 0.134
  10. Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain. J Biol Chem. 2020 03 13; 295(11):3553-3562.
    View in: PubMed
    Score: 0.122
  11. Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord. J Pharmacol Exp Ther. 2019 11; 371(2):242-249.
    View in: PubMed
    Score: 0.119
  12. a2d-1-Bound N-Methyl-D-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents. Anesthesiology. 2019 05; 130(5):804-819.
    View in: PubMed
    Score: 0.116
  13. Endogenous transient receptor potential ankyrin 1 and vanilloid 1 activity potentiates glutamatergic input to spinal lamina I neurons in inflammatory pain. J Neurochem. 2019 05; 149(3):381-398.
    View in: PubMed
    Score: 0.115
  14. Increased a2d-1-NMDA receptor coupling potentiates glutamatergic input to spinal dorsal horn neurons in chemotherapy-induced neuropathic pain. J Neurochem. 2019 01; 148(2):252-274.
    View in: PubMed
    Score: 0.113
  15. Mitogen-activated protein kinase signaling mediates opioid-induced presynaptic NMDA receptor activation and analgesic tolerance. J Neurochem. 2019 01; 148(2):275-290.
    View in: PubMed
    Score: 0.113
  16. RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons. J Biol Chem. 2018 12 07; 293(49):19078-19091.
    View in: PubMed
    Score: 0.112
  17. a2d-1 Is Essential for Sympathetic Output and NMDA Receptor Activity Potentiated by Angiotensin II in the Hypothalamus. J Neurosci. 2018 07 11; 38(28):6388-6398.
    View in: PubMed
    Score: 0.109
  18. Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury. Neuropharmacology. 2017 Oct; 125:156-165.
    View in: PubMed
    Score: 0.103
  19. Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord. Neuropharmacology. 2017 Sep 01; 123:477-487.
    View in: PubMed
    Score: 0.102
  20. Chloride Homeostasis Critically Regulates Synaptic NMDA Receptor Activity in Neuropathic Pain. Cell Rep. 2016 05 17; 15(7):1376-1383.
    View in: PubMed
    Score: 0.094
  21. Nerve Injury Diminishes Opioid Analgesia through Lysine Methyltransferase-mediated Transcriptional Repression of ?-Opioid Receptors in Primary Sensory Neurons. J Biol Chem. 2016 Apr 15; 291(16):8475-85.
    View in: PubMed
    Score: 0.093
  22. Muscarinic receptor subtypes differentially control synaptic input and excitability of cerebellum-projecting medial vestibular nucleus neurons. J Neurochem. 2016 Apr; 137(2):226-39.
    View in: PubMed
    Score: 0.093
  23. G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition. Nat Neurosci. 2015 Dec; 18(12):1746-55.
    View in: PubMed
    Score: 0.091
  24. Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development. J Biol Chem. 2015 Jun 05; 290(23):14647-55.
    View in: PubMed
    Score: 0.088
  25. Increased spinal cord Na?-K?-2Cl? cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic pain. J Biol Chem. 2014 Nov 07; 289(45):31111-20.
    View in: PubMed
    Score: 0.084
  26. Casein kinase II regulates N-methyl-D-aspartate receptor activity in spinal cords and pain hypersensitivity induced by nerve injury. J Pharmacol Exp Ther. 2014 Aug; 350(2):301-12.
    View in: PubMed
    Score: 0.082
  27. Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor. J Pharmacol Exp Ther. 2014 May; 349(2):239-47.
    View in: PubMed
    Score: 0.081
  28. Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords. J Physiol. 2014 Jan 01; 592(1):215-27.
    View in: PubMed
    Score: 0.079
  29. Nerve injury increases GluA2-lacking AMPA receptor prevalence in spinal cords: functional significance and signaling mechanisms. J Pharmacol Exp Ther. 2013 Dec; 347(3):765-72.
    View in: PubMed
    Score: 0.078
  30. Distinct intrinsic and synaptic properties of pre-sympathetic and pre-parasympathetic output neurons in Barrington's nucleus. J Neurochem. 2013 Aug; 126(3):338-48.
    View in: PubMed
    Score: 0.077
  31. Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain. J Pharmacol Exp Ther. 2013 Apr; 345(1):161-8.
    View in: PubMed
    Score: 0.075
  32. N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl- cotransporter-2 impairs spinal chloride homeostasis in neuropathic pain. J Biol Chem. 2012 Sep 28; 287(40):33853-64.
    View in: PubMed
    Score: 0.073
  33. Chronic opioid potentiates presynaptic but impairs postsynaptic N-methyl-D-aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance. J Biol Chem. 2012 Jul 20; 287(30):25073-85.
    View in: PubMed
    Score: 0.072
  34. Nerve injury increases brain-derived neurotrophic factor levels to suppress BK channel activity in primary sensory neurons. J Neurochem. 2012 Jun; 121(6):944-53.
    View in: PubMed
    Score: 0.071
  35. Up-regulation of Cav?3 subunit in primary sensory neurons increases voltage-activated Ca2+ channel activity and nociceptive input in neuropathic pain. J Biol Chem. 2012 Feb 17; 287(8):6002-13.
    View in: PubMed
    Score: 0.070
  36. Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons. J Neurochem. 2011 Nov; 119(3):594-603.
    View in: PubMed
    Score: 0.068
  37. Nitric oxide inhibits nociceptive transmission by differentially regulating glutamate and glycine release to spinal dorsal horn neurons. J Biol Chem. 2011 Sep 23; 286(38):33190-202.
    View in: PubMed
    Score: 0.068
  38. Increased presynaptic and postsynaptic a2-adrenoceptor activity in the spinal dorsal horn in painful diabetic neuropathy. J Pharmacol Exp Ther. 2011 Apr; 337(1):285-92.
    View in: PubMed
    Score: 0.065
  39. Functional plasticity of group II metabotropic glutamate receptors in regulating spinal excitatory and inhibitory synaptic input in neuropathic pain. J Pharmacol Exp Ther. 2011 Jan; 336(1):254-64.
    View in: PubMed
    Score: 0.064
  40. Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. J Neurochem. 2010 Sep 01; 114(5):1460-75.
    View in: PubMed
    Score: 0.063
  41. Opioid-induced long-term potentiation in the spinal cord is a presynaptic event. J Neurosci. 2010 Mar 24; 30(12):4460-6.
    View in: PubMed
    Score: 0.062
  42. Adenosine inhibits paraventricular pre-sympathetic neurons through ATP-dependent potassium channels. J Neurochem. 2010 Apr; 113(2):530-42.
    View in: PubMed
    Score: 0.061
  43. Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. J Biol Chem. 2009 Dec 25; 284(52):36453-36461.
    View in: PubMed
    Score: 0.060
  44. Regulation of increased glutamatergic input to spinal dorsal horn neurons by mGluR5 in diabetic neuropathic pain. J Neurochem. 2010 Jan; 112(1):162-72.
    View in: PubMed
    Score: 0.060
  45. Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats. J Neurochem. 2009 Nov; 111(4):1000-10.
    View in: PubMed
    Score: 0.060
  46. Sensing of blood pressure increase by transient receptor potential vanilloid 1 receptors on baroreceptors. J Pharmacol Exp Ther. 2009 Dec; 331(3):851-9.
    View in: PubMed
    Score: 0.059
  47. Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain. Neuropharmacology. 2009 Aug; 57(2):121-6.
    View in: PubMed
    Score: 0.058
  48. Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain. J Neurochem. 2009 Jul; 110(1):352-62.
    View in: PubMed
    Score: 0.058
  49. A functional link between T-type calcium channels and mu-opioid receptor expression in adult primary sensory neurons. J Neurochem. 2009 May; 109(3):867-78.
    View in: PubMed
    Score: 0.057
  50. Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord. Neuroscience. 2009 Feb 18; 158(4):1577-88.
    View in: PubMed
    Score: 0.056
  51. Stimulation of alpha(1)-adrenoceptors reduces glutamatergic synaptic input from primary afferents through GABA(A) receptors and T-type Ca(2+) channels. Neuroscience. 2009 Feb 18; 158(4):1616-24.
    View in: PubMed
    Score: 0.056
  52. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn. J Neurochem. 2009 Jan; 108(1):305-18.
    View in: PubMed
    Score: 0.056
  53. Effects of activation of group III metabotropic glutamate receptors on spinal synaptic transmission in a rat model of neuropathic pain. Neuroscience. 2009 Jan 23; 158(2):875-84.
    View in: PubMed
    Score: 0.056
  54. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord. J Pharmacol Exp Ther. 2008 Nov; 327(2):375-82.
    View in: PubMed
    Score: 0.055
  55. Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception. Neuropharmacology. 2008 Aug; 55(2):215-22.
    View in: PubMed
    Score: 0.054
  56. Distinct inhibition of voltage-activated Ca2+ channels by delta-opioid agonists in dorsal root ganglion neurons devoid of functional T-type Ca2+ currents. Neuroscience. 2008 Jun 02; 153(4):1256-67.
    View in: PubMed
    Score: 0.054
  57. Increased C-fiber nociceptive input potentiates inhibitory glycinergic transmission in the spinal dorsal horn. J Pharmacol Exp Ther. 2008 Mar; 324(3):1000-10.
    View in: PubMed
    Score: 0.053
  58. Kv1.1/1.2 channels are downstream effectors of nitric oxide on synaptic GABA release to preautonomic neurons in the paraventricular nucleus. Neuroscience. 2007 Oct 26; 149(2):315-27.
    View in: PubMed
    Score: 0.051
  59. Role of TRPV1 and intracellular Ca2+ in excitation of cardiac sensory neurons by bradykinin. Am J Physiol Regul Integr Comp Physiol. 2007 Jul; 293(1):R276-83.
    View in: PubMed
    Score: 0.051
  60. Potentiation of spinal alpha(2)-adrenoceptor analgesia in rats deficient in TRPV1-expressing afferent neurons. Neuropharmacology. 2007 Jun; 52(8):1624-30.
    View in: PubMed
    Score: 0.050
  61. Signaling mechanisms of angiotensin II-induced attenuation of GABAergic input to hypothalamic presympathetic neurons. J Neurophysiol. 2007 May; 97(5):3279-87.
    View in: PubMed
    Score: 0.050
  62. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons. Neuroscience. 2007 Mar 16; 145(2):676-85.
    View in: PubMed
    Score: 0.049
  63. Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy. J Physiol. 2007 Mar 15; 579(Pt 3):849-61.
    View in: PubMed
    Score: 0.049
  64. Increased nociceptive input rapidly modulates spinal GABAergic transmission through endogenously released glutamate. J Neurophysiol. 2007 Jan; 97(1):871-82.
    View in: PubMed
    Score: 0.049
  65. Role of gamma-aminobutyric acid (GABA)A and GABAB receptors in paraventricular nucleus in control of sympathetic vasomotor tone in hypertension. J Pharmacol Exp Ther. 2007 Feb; 320(2):615-26.
    View in: PubMed
    Score: 0.049
  66. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes. J Neurophysiol. 2007 Jan; 97(1):102-9.
    View in: PubMed
    Score: 0.049
  67. Benzodiazepine inhibits hypothalamic presympathetic neurons by potentiation of GABAergic synaptic input. Neuropharmacology. 2007 Feb; 52(2):467-75.
    View in: PubMed
    Score: 0.049
  68. Regulation of synaptic input to hypothalamic presympathetic neurons by GABA(B) receptors. Neuroscience. 2006 Oct 13; 142(2):595-606.
    View in: PubMed
    Score: 0.048
  69. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons. Neuroscience. 2006 Aug 11; 141(1):407-19.
    View in: PubMed
    Score: 0.047
  70. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Brain Res. 2006 Apr 07; 1081(1):119-25.
    View in: PubMed
    Score: 0.046
  71. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. J Neurophysiol. 2006 May; 95(5):3086-96.
    View in: PubMed
    Score: 0.046
  72. Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats. J Physiol. 2006 Mar 01; 571(Pt 2):403-13.
    View in: PubMed
    Score: 0.046
  73. Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels. J Neurophysiol. 2006 Apr; 95(4):2032-41.
    View in: PubMed
    Score: 0.046
  74. Presynaptic alpha1 adrenergic receptors differentially regulate synaptic glutamate and GABA release to hypothalamic presympathetic neurons. J Pharmacol Exp Ther. 2006 Feb; 316(2):733-42.
    View in: PubMed
    Score: 0.045
  75. Plasticity of GABAergic control of hypothalamic presympathetic neurons in hypertension. Am J Physiol Heart Circ Physiol. 2006 Mar; 290(3):H1110-9.
    View in: PubMed
    Score: 0.045
  76. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain. J Pharmacol Exp Ther. 2005 Nov; 315(2):696-703.
    View in: PubMed
    Score: 0.045
  77. Effect of systemic and intrathecal gabapentin on allodynia in a new rat model of postherpetic neuralgia. Brain Res. 2005 Apr 25; 1042(1):108-13.
    View in: PubMed
    Score: 0.044
  78. Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calcium-dependent calcineurin in sensory neurons. J Biol Chem. 2005 May 06; 280(18):18142-51.
    View in: PubMed
    Score: 0.043
  79. Angiotensin II attenuates synaptic GABA release and excites paraventricular-rostral ventrolateral medulla output neurons. J Pharmacol Exp Ther. 2005 Jun; 313(3):1035-45.
    View in: PubMed
    Score: 0.043
  80. A-type voltage-gated K+ currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons. J Neurophysiol. 2005 Jun; 93(6):3401-9.
    View in: PubMed
    Score: 0.043
  81. M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons. J Pharmacol Exp Ther. 2005 May; 313(2):697-704.
    View in: PubMed
    Score: 0.043
  82. Tetrodotoxin-sensitive and -resistant Na+ channel currents in subsets of small sensory neurons of rats. Brain Res. 2004 Dec 17; 1029(2):251-8.
    View in: PubMed
    Score: 0.043
  83. Role of paraventricular nucleus in the cardiogenic sympathetic reflex in rats. Am J Physiol Regul Integr Comp Physiol. 2005 Feb; 288(2):R420-6.
    View in: PubMed
    Score: 0.042
  84. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala. J Pharmacol Exp Ther. 2005 Feb; 312(2):441-8.
    View in: PubMed
    Score: 0.042
  85. High voltage-activated Ca(2+) channel currents in isolectin B(4)-positive and -negative small dorsal root ganglion neurons of rats. Neurosci Lett. 2004 Sep 16; 368(1):96-101.
    View in: PubMed
    Score: 0.042
  86. Distinct roles of group III metabotropic glutamate receptors in control of nociception and dorsal horn neurons in normal and nerve-injured Rats. J Pharmacol Exp Ther. 2005 Jan; 312(1):120-6.
    View in: PubMed
    Score: 0.042
  87. Regulation of synaptic inputs to paraventricular-spinal output neurons by alpha2 adrenergic receptors. J Neurophysiol. 2005 Jan; 93(1):393-402.
    View in: PubMed
    Score: 0.042
  88. Differential sensitivity of N- and P/Q-type Ca2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther. 2004 Dec; 311(3):939-47.
    View in: PubMed
    Score: 0.042
  89. VR1 receptor activation induces glutamate release and postsynaptic firing in the paraventricular nucleus. J Neurophysiol. 2004 Sep; 92(3):1807-16.
    View in: PubMed
    Score: 0.041
  90. Activation of mu-opioid receptors excites a population of locus coeruleus-spinal neurons through presynaptic disinhibition. Brain Res. 2004 Jan 30; 997(1):67-78.
    View in: PubMed
    Score: 0.040
  91. Primary afferent stimulation differentially potentiates excitatory and inhibitory inputs to spinal lamina II outer and inner neurons. J Neurophysiol. 2004 Jun; 91(6):2413-21.
    View in: PubMed
    Score: 0.040
  92. Activation of mu-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons. J Pharmacol Exp Ther. 2004 May; 309(2):476-83.
    View in: PubMed
    Score: 0.040
  93. Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus. J Physiol. 2004 Jan 01; 554(Pt 1):100-10.
    View in: PubMed
    Score: 0.040
  94. Activation of muscarinic receptors inhibits spinal dorsal horn projection neurons: role of GABAB receptors. Neuroscience. 2004; 125(1):141-8.
    View in: PubMed
    Score: 0.040
  95. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology. 2003 Dec; 99(6):1409-14.
    View in: PubMed
    Score: 0.040
  96. Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats. J Pharmacol Exp Ther. 2003 Nov; 307(2):676-81.
    View in: PubMed
    Score: 0.039
  97. Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol. 2003 Sep 01; 551(Pt 2):515-23.
    View in: PubMed
    Score: 0.039
  98. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci. 2003 Jun 15; 23(12):5041-9.
    View in: PubMed
    Score: 0.039
  99. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J Neurosci. 2003 Apr 01; 23(7):2911-9.
    View in: PubMed
    Score: 0.038
  100. Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats. Brain Res. 2003 Mar 07; 965(1-2):67-74.
    View in: PubMed
    Score: 0.038
  101. Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats. Anesthesiology. 2003 Jan; 98(1):217-22.
    View in: PubMed
    Score: 0.037
  102. Role of spinal nitric oxide in the inhibitory effect of [D-Pen2, D-Pen5]-enkephalin on ascending dorsal horn neurons in normal and diabetic rats. J Pharmacol Exp Ther. 2002 Dec; 303(3):1021-8.
    View in: PubMed
    Score: 0.037
  103. Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology. 2002 Dec; 97(6):1602-8.
    View in: PubMed
    Score: 0.037
  104. Nitric oxide inhibits spinally projecting paraventricular neurons through potentiation of presynaptic GABA release. J Neurophysiol. 2002 Nov; 88(5):2664-74.
    View in: PubMed
    Score: 0.037
  105. Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic inputs. J Neurophysiol. 2002 Nov; 88(5):2675-83.
    View in: PubMed
    Score: 0.037
  106. Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol. 2002 Sep 15; 543(Pt 3):807-18.
    View in: PubMed
    Score: 0.037
  107. Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J Neurophysiol. 2002 Jun; 87(6):2726-33.
    View in: PubMed
    Score: 0.036
  108. Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors. J Neurophysiol. 2002 Apr; 87(4):1938-47.
    View in: PubMed
    Score: 0.035
  109. Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain. J Pharmacol Exp Ther. 2002 Feb; 300(2):662-7.
    View in: PubMed
    Score: 0.035
  110. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience. 2002; 114(2):291-9.
    View in: PubMed
    Score: 0.035
  111. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Anesthesiology. 2001 Dec; 95(6):1473-9.
    View in: PubMed
    Score: 0.035
  112. Acetylcholine attenuates synaptic GABA release to supraoptic neurons through presynaptic nicotinic receptors. Brain Res. 2001 Nov 30; 920(1-2):151-8.
    View in: PubMed
    Score: 0.035
  113. Potentiation of glutamatergic synaptic input to supraoptic neurons by presynaptic nicotinic receptors. Am J Physiol Regul Integr Comp Physiol. 2001 Oct; 281(4):R1105-13.
    View in: PubMed
    Score: 0.034
  114. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. Anesthesiology. 2001 Oct; 95(4):1007-12.
    View in: PubMed
    Score: 0.034
  115. Differential roles for glutamate receptor subtypes within commissural NTS in cardiac-sympathetic reflex. Am J Physiol Regul Integr Comp Physiol. 2001 Sep; 281(3):R935-43.
    View in: PubMed
    Score: 0.034
  116. Allosteric adenosine modulation to reduce allodynia. Anesthesiology. 2001 Aug; 95(2):416-20.
    View in: PubMed
    Score: 0.034
  117. Spinal endogenous acetylcholine contributes to the analgesic effect of systemic morphine in rats. Anesthesiology. 2001 Aug; 95(2):525-30.
    View in: PubMed
    Score: 0.034
  118. Responses of neurons in rostral ventrolateral medulla to activation of cardiac receptors in rats. Am J Physiol Heart Circ Physiol. 2000 Nov; 279(5):H2549-57.
    View in: PubMed
    Score: 0.032
  119. Role of spinal muscarinic and nicotinic receptors in clonidine-induced nitric oxide release in a rat model of neuropathic pain. Brain Res. 2000 Apr 10; 861(2):390-8.
    View in: PubMed
    Score: 0.031
  120. Synergistic effect between intrathecal non-NMDA antagonist and gabapentin on allodynia induced by spinal nerve ligation in rats. Anesthesiology. 2000 Feb; 92(2):500-6.
    View in: PubMed
    Score: 0.031
  121. Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience. 2000; 97(4):743-8.
    View in: PubMed
    Score: 0.030
  122. Intrathecal S-nitroso-N-acetylpenicillamine and L-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation in rats. Neuroscience. 2000; 101(3):759-65.
    View in: PubMed
    Score: 0.030
  123. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther. 1999 Mar; 288(3):1026-30.
    View in: PubMed
    Score: 0.029
  124. Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors. Anesthesiology. 1999 Feb; 90(2):509-14.
    View in: PubMed
    Score: 0.028
  125. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology. 1998 Dec; 89(6):1518-23.
    View in: PubMed
    Score: 0.028
  126. Glutamate-activated BK channel complexes formed with NMDA receptors. Proc Natl Acad Sci U S A. 2018 09 18; 115(38):E9006-E9014.
    View in: PubMed
    Score: 0.028
  127. Effects of intrathecal neostigmine, bupivacaine, and their combination on sympathetic nerve activity in rats. Anesthesiology. 1998 Feb; 88(2):481-6.
    View in: PubMed
    Score: 0.027
  128. Electroacupuncture improves thermal and mechanical sensitivities in a rat model of postherpetic neuralgia. Mol Pain. 2013 Apr 03; 9:18.
    View in: PubMed
    Score: 0.019
  129. Cannabinoids suppress inflammatory and neuropathic pain by targeting a3 glycine receptors. J Exp Med. 2012 Jun 04; 209(6):1121-34.
    View in: PubMed
    Score: 0.018
  130. Cannabinoid CB2 receptors contribute to upregulation of ?-endorphin in inflamed skin tissues by electroacupuncture. Mol Pain. 2011 Dec 19; 7:98.
    View in: PubMed
    Score: 0.017
  131. Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats. J Pain. 2010 Dec; 11(12):1250-8.
    View in: PubMed
    Score: 0.016
  132. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats. J Pain. 2009 Jul; 10(7):732-9.
    View in: PubMed
    Score: 0.015
  133. Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism. J Pharmacol Exp Ther. 2003 Jun; 305(3):950-5.
    View in: PubMed
    Score: 0.009
  134. Effect of kappa opioid agonists on visceral nociception induced by uterine cervical distension in rats. Pain. 2002 Mar; 96(1-2):13-22.
    View in: PubMed
    Score: 0.009
  135. Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J Neurosci. 2001 Jul 15; 21(14):5358-66.
    View in: PubMed
    Score: 0.008
  136. Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord. Brain Res. 2001 Mar 23; 895(1-2):1-8.
    View in: PubMed
    Score: 0.008
  137. S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes. Brain Res. 2000 Jul 28; 872(1-2):301-7.
    View in: PubMed
    Score: 0.008
  138. Norepinephrine release from spinal synaptosomes: auto-alpha2 -adrenergic receptor modulation. Anesthesiology. 2000 Jul; 93(1):164-72.
    View in: PubMed
    Score: 0.008
  139. Antiallodynic effect of intrathecal gabapentin and its interaction with clonidine in a rat model of postoperative pain. Anesthesiology. 2000 Apr; 92(4):1126-31.
    View in: PubMed
    Score: 0.008
  140. 6-NO(2)-norepinephrine increases norepinephrine release and inhibits norepinephrine uptake in rat spinal synaptosomes. J Pharmacol Exp Ther. 2000 Mar; 292(3):895-9.
    View in: PubMed
    Score: 0.008
  141. Formation of 6-nitro-norepinephrine from nitric oxide and norepinephrine in the spinal cord and its role in spinal analgesia. Neuroscience. 2000; 101(1):189-96.
    View in: PubMed
    Score: 0.008
  142. Sex differences in cholinergic analgesia I: a supplemental nicotinic mechanism in normal females. Anesthesiology. 1999 Nov; 91(5):1447-54.
    View in: PubMed
    Score: 0.008
  143. Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology. 1999 Oct; 91(4):1072-9.
    View in: PubMed
    Score: 0.007
  144. Intrathecal neostigmine, but not sympathectomy, relieves mechanical allodynia in a rat model of neuropathic pain. Anesthesiology. 1998 Aug; 89(2):493-9.
    View in: PubMed
    Score: 0.007
  145. Spinal nitric oxide mediates antinociception from intravenous morphine. Anesthesiology. 1998 Jul; 89(1):215-21.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.